Psychedelics on the N.Y. Times front page
“Dr. Doblin’s quest to win mainstream acceptance of psychedelics took a significant leap forward on Monday when the journal Nature Medicine published the results of his lab’s study on MDMA,
Psyon is a specialized professional facility focusing on the therapeutic use of psychedelics in the treatment of mental illness. We are the first European clinic to provide ketamine-assisted psychotherapy as an alternative to common treatments.